MigraineNCT06536920
Migraine Among Sohag University Students
An observational study of Migraine, run by Sohag University at 1 site in Egypt.
Trial summary
Diagnosis of migraine among students and detect frequency among them and detect how far migraine affect their life Read more about this study
- Who is it for?
- Ages 18 to 25 yearsHealthy volunteers can take part
- Conditions the study is for
- Migraine
- What is being tested?
- Migraine screening questionnaire
- How many people
- 500 participants
- Where
- 1 siteEgypt
- Study dates
- 1 Oct 2024to 1 Oct 2025
- Phase
- Observational
- Are there results?
- None posted in the registry
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 18 to 25 years
- All sexes
- Healthy volunteers accepted
- Adult
Study population: Sohag university students
Who may be able to join
- Age from 18 to 25 years old.
- students accept to give informed consent
Who cannot join
- Students refused to give informed consent
- Age less than 18 or more than 25 ears old.
Trial locations and contacts
1 site in 1 country.
About this study
Official title: Frequency and Impact of Migraine Among Sohag University Students
Diagnosis of migraine among students and detect frequency among them and detect how far migraine affect their life
- Conditions
- Migraine
- Being tested
- Migraine screening questionnaire
- Medical subject headings
- Migraine Disorders
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
Migraine screening questionnaireDiagnostic test
Screening test
| Study group | Role | What they receive |
|---|---|---|
| Sohag university students | Who diagnosed as migraine among sohag university students Receives: Diagnostic Test: Migraine screening questionnaire |
What is being measured
The primary outcome is the main question the study is designed to answer.
Migraine screening questionnaire
Knowing frequency of migarine and impact of migraine on students' normal life
Measured: 1 year
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted5 Aug 2024
- Study start1 Oct 2024 (estimated)
- Primary completion1 May 2025 (estimated)
- Study completion1 Oct 2025 (estimated)
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Other trials for MigraineStudies of the same condition, open and under way.
- More trials run by Sohag UniversityThe sponsor's other registered studies.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Observational
- Observational model
- Case crossover
- Time perspective
- Cross-sectional
- Enrolment
- 500 participants (estimated)
Sponsor and investigators
- Lead sponsor
- Sohag University
- Sponsor type
- University, hospital or other
- Responsible party
- Principal investigator, Ahmed ElSayed Sadek, Sohag University
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT06536920
- Sponsor's protocol ID
- Soh-24-05-03MS
- Status last verified
- Jul 2024
- First submitted
- 31 Jul 2024
- Last updated
- 5 Aug 2024
- Results posted
- No
- FDA-regulated drug
- No
- FDA-regulated device
- No
Study at a glance
From the registry record, last updated by the sponsor on 5 Aug 2024. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- Frequency and Impact of Migraine Among Sohag University Students
- ClinicalTrials.gov ID
- NCT06536920
- Acronym / sponsor ID
- Soh-24-05-03MS
- Conditions
- Migraine
- Study type
- Observational
- Recruitment status
- Unknown status
- Enrolment
- 500 participants (estimated)
- Lead sponsor
- Sohag UniversityUniversity, hospital or other
- Study start
- 1 Oct 2024 (estimated)
- Primary completion
- 1 May 2025 (estimated)
- Study completion
- 1 Oct 2025 (estimated)
- First posted
- 5 Aug 2024 (actual)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
Diagnosis of migraine among students and detect frequency among them and detect how far migraine affect their life
Study design
- Observational model
- Case crossover
- Time perspective
- Cross-sectional
- Number of arms
- 1
| Arm | Type | Receives |
|---|---|---|
| Sohag university students | – | Diagnostic Test: Migraine screening questionnaireWho diagnosed as migraine among sohag university students |
Who may qualify
- Ages
- 18 to 25 years
- Sex
- All
- Healthy volunteers
- Accepted
- Age groups
- Adult
- Study population
- Sohag university students
Key inclusion criteria (2 listed)
- Age from 18 to 25 years old.
- students accept to give informed consent
Key exclusion criteria (2 listed)
- Students refused to give informed consent
- Age less than 18 or more than 25 ears old.
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Interventions
| Intervention | Type | Arms |
|---|---|---|
| Migraine screening questionnaireScreening test | Diagnostic test | Sohag university students |
Primary outcome
Migraine screening questionnaire
Time frame: 1 year
Knowing frequency of migarine and impact of migraine on students' normal life
Results and safety
Results are not available in the source record.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 5 Aug 2024.
Related trials for Migraine
RecruitingObservational study
Study of the Glymphatic System in Migraine
Migraine
Active, not recruiting
Clinical and Neurophysiological Effects of tDCS to Visual and Motor Cortex in Migraine
Migraine
Active, not recruiting
App-Based Migraine Treatment: The Health enSuite Study
Migraine, Migraine With Aura
Not yet recruiting
A Prospective Study of Rimegepant for Short-term Preventive Treatment of Night-shift-related Migraine in Healthcare Professionals
Migraine Disorders
Recruiting
Marine Lipids Ease Painful TMD
Temporomandibular Disorder (TMD)
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part. This study is not recruiting at the moment.
1 site in 1 country: see every site and its status.
Questions about this trial
What is this clinical trial studying?
An observational study of Migraine, run by Sohag University at 1 site in Egypt.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 2 inclusion and 2 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: status not confirmed, as of the sponsor's last update on 5 Aug 2024. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 1 site in Egypt. Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
Results are not available in the source record.
How can a doctor refer a patient or contact the research team?
Contact Ahmed Elsayed Sedek (01122816728, doctor.ahmedelsayed95@gmail.com), or a site near the patient. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
Migraine screening questionnaire (time frame: 1 year). It is what the study was designed to measure, not a finding.
Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 5 Aug 2024.